Luisa Warchavchik Hugerth
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Luisa Warchavchik Hugerth has a total of 164 co-authors. Here are the top co-authors by number of shared publications:
- Lars Engstrand
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
12 shared publications - Ina Schuppe-Koistinen
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
8 shared publications - Anders F. Andersson
KTH Royal Institute of Technology, Department of Gene Technology, Science for Life Laboratory, Stockholm, Sweden
7 shared publications - Emma Fransson
Department of Women's and Children's Health, Uppsala University, 751 85 Uppsala, Sweden; Institute of Environmental Medicine, Karolinska Institutet, 17177 Stockholm, Sweden
7 shared publications - Henriette Svarre Nielsen
Department of Obstetrics and Gynecology, The Fertility Clinic Copenhagen University Hospital Hvidovre Hvidovre Denmark
5 shared publications - Fredrik Boulund
Centre for Translational Microbiome Research, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Solna, Sweden
4 shared publications
Latest Publications
- Open Access
- 15 October 2026
- Published by Oxford University Press (OUP) in Human Reproduction Update
Vaginal microbiome composition and medically assisted reproduction outcomes: a systematic review and network meta-analysis of 2289 women across three WHO regions
BACKGROUND: The vaginal microbiome may influence the success of medically assisted reproduction (MAR), including IVF with or without ICSI, and IUI. However, findings across studies remain inconsistent, and previous meta-analyses have largely relied on binary microbiome classifications or pairwise comparisons. The relative associations between individual vaginal community state types (CSTs) and pregnancy outcomes therefore remain uncertain. OBJECTIVE AND RATIONALE: To compare the associations between individual CSTs and pregnancy following MAR by integrating direct and indirect evidence in a systematic review and network meta-analysis (NMA) and to determine whether specific CSTs were associated with lower odds of pregnancy. SEARCH METHODS: PubMed, Embase, Web of Science, and the Cochrane Library were searched from database inception to 2 April 2026. Eligible longitudinal studies assessed vaginal microbiome composition using sequencing-based profiling before embryo transfer or IUI and reported pregnancy following MAR. Cross-sectional studies, studies without CST classification, or pregnancy outcome data, and studies based solely on post-treatment sampling were excluded. Two reviewers independently performed study selection and risk-of-bias assessment. Odds ratios (ORs) with 95% CIs were synthesized across CSTs using NMA. Twelve longitudinal studies including 2289 women met the inclusion criteria. The prospectively registered review was reported in accordance with PRISMA and the PRISMA extension for NMA. OUTCOMES: The NMA allowed integration of direct and indirect evidence across six CST categories. Compared with Lactobacillus (L.) crispatus, Lactobacillus jensenii-dominated CSTs (OR 0.42, 95% CI 0.19–0.92), and low-lactobacillus community CSTs (OR 0.59, 95% CI 0.38–0.91) were associated with significantly lower odds of pregnancy. No statistically significant differences were observed for other lactobacilli, including Lactobacillus gasseri and Lactobacillus iners, compared with L. crispatus. Tests found no evidence of overall or loop inconsistency in the primary network. Subgroup analyses showed broadly similar patterns but were limited by sparse data, imprecision, and local inconsistency in some subgroup networks. Interpretation was further limited by clinical and methodological heterogeneity, observational study designs, residual confounding, and sparse evidence for several CST comparisons. Live-birth evidence was particularly limited: only five studies reported a total of 57 live births. Transitivity could not be formally assessed because potential effect modifiers were not consistently reported for individual CSTs. WIDER IMPLICATIONS: The findings indicate that general assumption of Lactobacillus-dominated CSTs being beneficial to MAR-treatment effects should be regarded with caution, as these may differ in their associations with pregnancy, depending on the specific Lactobacillus dominance. However, the available evidence is insufficient to support clinical implementation of CST profiling. Larger, standardized prospective longitudinal studies with CST-specific reporting, adjusted estimates, repeated microbiome sampling, and live-birth outcomes are required to determine whether CST profiling has clinically useful prognostic value and whether microbiome-targeted interventions improve reproductive outcomes. REGISTRATION NUMBER: PROSPERO CRD420251066092.
- 15 October 2026
- Published by Oxford University Press (OUP) in Human Reproduction Update
Open AccessVaginal microbiome composition and medically assisted reproduction outcomes: a systematic review and network meta-analysis of 2289 women across three WHO regions
BACKGROUND: The vaginal microbiome may influence the success of medically assisted reproduction (MAR), including IVF with or without ICSI, and IUI. However, findings across studies remain inconsistent, and previous meta-analyses have largely relied on binary microbiome classifications or pairwise comparisons. The relative associations between individual vaginal community state types (CSTs) and pregnancy outcomes therefore remain uncertain. OBJECTIVE AND RATIONALE: To compare the associations between individual CSTs and pregnancy following MAR by integrating direct and indirect evidence in a systematic review and network meta-analysis (NMA) and to determine whether specific CSTs were associated with lower odds of pregnancy. SEARCH METHODS: PubMed, Embase, Web of Science, and the Cochrane Library were searched from database inception to 2 April 2026. Eligible longitudinal studies assessed vaginal microbiome composition using sequencing-based profiling before embryo transfer or IUI and reported pregnancy following MAR. Cross-sectional studies, studies without CST classification, or pregnancy outcome data, and studies based solely on post-treatment sampling were excluded. Two reviewers independently performed study selection and risk-of-bias assessment. Odds ratios (ORs) with 95% CIs were synthesized across CSTs using NMA. Twelve longitudinal studies including 2289 women met the inclusion criteria. The prospectively registered review was reported in accordance with PRISMA and the PRISMA extension for NMA. OUTCOMES: The NMA allowed integration of direct and indirect evidence across six CST categories. Compared with Lactobacillus (L.) crispatus, Lactobacillus jensenii-dominated CSTs (OR 0.42, 95% CI 0.19–0.92), and low-lactobacillus community CSTs (OR 0.59, 95% CI 0.38–0.91) were associated with significantly lower odds of pregnancy. No statistically significant differences were observed for other lactobacilli, including Lactobacillus gasseri and Lactobacillus iners, compared with L. crispatus. Tests found no evidence of overall or loop inconsistency in the primary network. Subgroup analyses showed broadly similar patterns but were limited by sparse data, imprecision, and local inconsistency in some subgroup networks. Interpretation was further limited by clinical and methodological heterogeneity, observational study designs, residual confounding, and sparse evidence for several CST comparisons. Live-birth evidence was particularly limited: only five studies reported a total of 57 live births. Transitivity could not be formally assessed because potential effect modifiers were not consistently reported for individual CSTs. WIDER IMPLICATIONS: The findings indicate that general assumption of Lactobacillus-dominated CSTs being beneficial to MAR-treatment effects should be regarded with caution, as these may differ in their associations with pregnancy, depending on the specific Lactobacillus dominance. However, the available evidence is insufficient to support clinical implementation of CST profiling. Larger, standardized prospective longitudinal studies with CST-specific reporting, adjusted estimates, repeated microbiome sampling, and live-birth outcomes are required to determine whether CST profiling has clinically useful prognostic value and whether microbiome-targeted interventions improve reproductive outcomes. REGISTRATION NUMBER: PROSPERO CRD420251066092.
- Open Access
Imputing relative abundances via Gaussian random fields
Longitudinal studies with human participants frequently face the challenge of missing samples, which lead to incomplete trajectories of participant biomarkers and a reduction in data size. Existing approaches focus on single-variable imputation or model features one at a time, while neural networks typically require a large number of parameters and substantial training data. To address these challenges, we present an explainable model for multiple imputation of compositional samples based on a Gaussian random field (GRF). The model is specifically designed for longitudinal data: it incorporates participant-specific information and accounts for both temporal dependence across repeated observations and within-sample correlations, while using a moderate number of parameters. By coupling the GRF with sparse activation functions, the framework outputs sum-constrained compositions and explicitly models zero inflation. Under the Aitchison and Jensen–Shannon distances, our framework achieves imputation accuracy comparable to that of an observation-carrying baseline, while overcoming its static nature by modeling temporal trajectories and multivariate correlations. The resulting multiple imputations allow us to reconstruct complete datasets for downstream analysis and uncertainty quantification. We demonstrate the practical utility of our framework on gut microbiome datasets, restoring incomplete time series and achieving a balanced accuracy of 0.72 in predicting food allergy in infants (sensitivity 0.8) and of 0.64 in forecasting postpartum depression.
Open AccessImputing relative abundances via Gaussian random fields
Longitudinal studies with human participants frequently face the challenge of missing samples, which lead to incomplete trajectories of participant biomarkers and a reduction in data size. Existing approaches focus on single-variable imputation or model features one at a time, while neural networks typically require a large number of parameters and substantial training data. To address these challenges, we present an explainable model for multiple imputation of compositional samples based on a Gaussian random field (GRF). The model is specifically designed for longitudinal data: it incorporates participant-specific information and accounts for both temporal dependence across repeated observations and within-sample correlations, while using a moderate number of parameters. By coupling the GRF with sparse activation functions, the framework outputs sum-constrained compositions and explicitly models zero inflation. Under the Aitchison and Jensen–Shannon distances, our framework achieves imputation accuracy comparable to that of an observation-carrying baseline, while overcoming its static nature by modeling temporal trajectories and multivariate correlations. The resulting multiple imputations allow us to reconstruct complete datasets for downstream analysis and uncertainty quantification. We demonstrate the practical utility of our framework on gut microbiome datasets, restoring incomplete time series and achieving a balanced accuracy of 0.72 in predicting food allergy in infants (sensitivity 0.8) and of 0.64 in forecasting postpartum depression.
- Open Access
Benchmarking virus identification tools on vaginal metagenomes
The vaginal microbiome is associated with reproductive and sexual health, yet its viral component remains understudied. A recent vaginal genome catalogue reported that 85.8% of its species-level viral groups were absent from all five viral databases examined. Viral identification tools depend on reference sequences, either directly or through their training data. Previous benchmarks used simulated or non-vaginal datasets. How well these tools generalise to vaginal metagenomes therefore remains unclear. We benchmarked 14 tools spanning five methodological approaches. Evaluations used controlled genome fragments, viral spike-in co-assemblies and virus-like particle (VLP)-enriched co-assemblies. A multi-evidence benchmark assessed 13 vaginal shotgun assemblies (primary cohort). An independent 30-sample cohort provided external validation. geNomad ranked first or second by Matthews correlation coefficient (MCC) in every ranked evaluation. VIBRANT achieved similar MCC to geNomad on the primary assemblies. It made eight false-positive calls among 11,577 negatives but recovered only 22% of viral contigs. VIBRANT ranked first in the independent cohort. Tool rankings agreed closely between cohorts (Spearman ρ = 0.952; 95% CI 0.921–0.960). Detection of sequences lacking reference homologues differed substantially between tools. Two phage genomes without detectable reference homologues provided a controlled novelty test. Each evaluated composition-based tool recovered at least 74% of their 1,500-bp fragments. Marker-or reference-dependent tools recovered at most 31%. A separate analysis examined 48 unconfirmed candidate viral contigs lacking detectable nucleotide or protein homologues. Jaeger flagged 41, compared with four for VIBRANT and one for geNomad. On short fragments, attention-based tools achieved 4.0–5.5 times the mean area under the precision–recall curve of feature-based tools. ViraLM accounted for most of this difference. ViraLM also had the highest recall (sensitivity) of eukaryote-infecting viruses in the evaluated panel. VirSorter2 achieved the highest MCC on VLP-enriched contigs. These results support geNomad when prioritising overall classification performance and VIBRANT when minimising false-positive phage calls is the priority. ViraLM supports short-contig and eukaryote-infecting-virus detection. VirSorter2 supports identification in VLP-enriched assemblies, and Jaeger supports screening for candidate novel phages. These findings guide tool selection for studies investigating the vaginal virome in reproductive and sexual health.
Open AccessBenchmarking virus identification tools on vaginal metagenomes
The vaginal microbiome is associated with reproductive and sexual health, yet its viral component remains understudied. A recent vaginal genome catalogue reported that 85.8% of its species-level viral groups were absent from all five viral databases examined. Viral identification tools depend on reference sequences, either directly or through their training data. Previous benchmarks used simulated or non-vaginal datasets. How well these tools generalise to vaginal metagenomes therefore remains unclear. We benchmarked 14 tools spanning five methodological approaches. Evaluations used controlled genome fragments, viral spike-in co-assemblies and virus-like particle (VLP)-enriched co-assemblies. A multi-evidence benchmark assessed 13 vaginal shotgun assemblies (primary cohort). An independent 30-sample cohort provided external validation. geNomad ranked first or second by Matthews correlation coefficient (MCC) in every ranked evaluation. VIBRANT achieved similar MCC to geNomad on the primary assemblies. It made eight false-positive calls among 11,577 negatives but recovered only 22% of viral contigs. VIBRANT ranked first in the independent cohort. Tool rankings agreed closely between cohorts (Spearman ρ = 0.952; 95% CI 0.921–0.960). Detection of sequences lacking reference homologues differed substantially between tools. Two phage genomes without detectable reference homologues provided a controlled novelty test. Each evaluated composition-based tool recovered at least 74% of their 1,500-bp fragments. Marker-or reference-dependent tools recovered at most 31%. A separate analysis examined 48 unconfirmed candidate viral contigs lacking detectable nucleotide or protein homologues. Jaeger flagged 41, compared with four for VIBRANT and one for geNomad. On short fragments, attention-based tools achieved 4.0–5.5 times the mean area under the precision–recall curve of feature-based tools. ViraLM accounted for most of this difference. ViraLM also had the highest recall (sensitivity) of eukaryote-infecting viruses in the evaluated panel. VirSorter2 achieved the highest MCC on VLP-enriched contigs. These results support geNomad when prioritising overall classification performance and VIBRANT when minimising false-positive phage calls is the priority. ViraLM supports short-contig and eukaryote-infecting-virus detection. VirSorter2 supports identification in VLP-enriched assemblies, and Jaeger supports screening for candidate novel phages. These findings guide tool selection for studies investigating the vaginal virome in reproductive and sexual health.
- Open Access
- 24 July 2026
- Published by Elsevier in SSRN Electronic Journal
Determinants of the Vaginal Microbiome across Ages and the Presence of Antimicrobial Resistance in Healthy Swedish Women
Background: The vaginal microbiome is important for women's health, – yet it remains insufficiently known which factors may affect microbiome composition, abundance and functionality. Methods: This cross-sectional study included 1445 healthy women attending cervical cancer screening. Leveraging extensive registry data and questionnaires (>200 potential determinants), we applied multivariate Supervised Component Generalized Linear Regression. Findings: Age, reproductive, sexual and mental health, and non-antibiotic drugs were drivers of microbial variation across reproductive life stages. Younger women exhibited higher Lactobacillus spp. abundance, whereas postmenopausal women demonstrated increased microbial diversity. Antimicrobial resistance genes were found in 74%. Interpretation: This exploratory study underscores the necessity of integrating multivariate statistical approaches in microbiome research to disentangle the complex interplay of covariates and functional metabolic effects. The extensive registry-linked dataset and population-based design provide a unique resource for future explorations of the intricate relationships between host factors, microbiome composition, and antimicrobial resistance in women’s health.
- 24 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessDeterminants of the Vaginal Microbiome across Ages and the Presence of Antimicrobial Resistance in Healthy Swedish Women
Background: The vaginal microbiome is important for women's health, – yet it remains insufficiently known which factors may affect microbiome composition, abundance and functionality. Methods: This cross-sectional study included 1445 healthy women attending cervical cancer screening. Leveraging extensive registry data and questionnaires (>200 potential determinants), we applied multivariate Supervised Component Generalized Linear Regression. Findings: Age, reproductive, sexual and mental health, and non-antibiotic drugs were drivers of microbial variation across reproductive life stages. Younger women exhibited higher Lactobacillus spp. abundance, whereas postmenopausal women demonstrated increased microbial diversity. Antimicrobial resistance genes were found in 74%. Interpretation: This exploratory study underscores the necessity of integrating multivariate statistical approaches in microbiome research to disentangle the complex interplay of covariates and functional metabolic effects. The extensive registry-linked dataset and population-based design provide a unique resource for future explorations of the intricate relationships between host factors, microbiome composition, and antimicrobial resistance in women’s health.
- Open Access
PLAGUE: Improved confidence plasmid reconstruction from short read assemblies
As the vast majority of archival data is short-read based, reliable strategies for detecting and classifying plasmids out of these data are still needed. A widely adopted solution for binning plasmids with rich contextual data is MOB-Suite. However, a large portion of the available data has low coverage and results in fragmented assemblies. Under these circumstances, MOB-Suite delivers a high number of false positives, leading to wasteful follow-up experiments. To improve the reliability of MOB-Suite, while retaining and enriching its biological contextual output, we have developed PLAGUE. PLAGUE is a fast and low-memory consumption post-processing tool for MOB-Suite outputs, relying on checks of circularity, reads spanning the gap between the 3’ and 5’ ends and total coverage of the plasmid candidate. PLAGUE can reduce the number of false positives in MOB-Suite outputs by over 30%, while retaining almost full sensitivity. It is fully containerized and easy to use in clusters as well as locally.
Open AccessPLAGUE: Improved confidence plasmid reconstruction from short read assemblies
As the vast majority of archival data is short-read based, reliable strategies for detecting and classifying plasmids out of these data are still needed. A widely adopted solution for binning plasmids with rich contextual data is MOB-Suite. However, a large portion of the available data has low coverage and results in fragmented assemblies. Under these circumstances, MOB-Suite delivers a high number of false positives, leading to wasteful follow-up experiments. To improve the reliability of MOB-Suite, while retaining and enriching its biological contextual output, we have developed PLAGUE. PLAGUE is a fast and low-memory consumption post-processing tool for MOB-Suite outputs, relying on checks of circularity, reads spanning the gap between the 3’ and 5’ ends and total coverage of the plasmid candidate. PLAGUE can reduce the number of false positives in MOB-Suite outputs by over 30%, while retaining almost full sensitivity. It is fully containerized and easy to use in clusters as well as locally.
- Top Cited PapersOpen Access
- 26 March 2026
- Published by Elsevier in The Lancet Microbe
- Vol. 7 (4) , 101294
Vaginal microbiota transplantation for treatment of vaginal dysbiosis without the use of antibiotics: a double-blind, randomised controlled trial in women with vaginal dysbiosis
- 26 March 2026
- Published by Elsevier in The Lancet Microbe
- Vol. 7 (4) , 101294
Top Cited PapersOpen AccessVaginal microbiota transplantation for treatment of vaginal dysbiosis without the use of antibiotics: a double-blind, randomised controlled trial in women with vaginal dysbiosis
- Open Access
- 22 December 2025
- Published by Taylor & Francis in Gut Microbes Reports
- Vol. 3 (1) , 2603861
The gut microbiome in early pregnancy is associated with the severity of nausea and vomiting: a nested case‒control study
Nausea and vomiting of pregnancy (NVP) are experienced by roughly 70% of pregnant individuals.1 Symptoms of nausea and/or vomiting can start as early as gestational week 4 and usually peak at week ...
- 22 December 2025
- Published by Taylor & Francis in Gut Microbes Reports
- Vol. 3 (1) , 2603861
Open AccessThe gut microbiome in early pregnancy is associated with the severity of nausea and vomiting: a nested case‒control study
Nausea and vomiting of pregnancy (NVP) are experienced by roughly 70% of pregnant individuals.1 Symptoms of nausea and/or vomiting can start as early as gestational week 4 and usually peak at week ...
- Open Access
- 15 November 2025
- Published by Springer Nature in BMC Microbiology
- Vol. 25 (1) , 750
Differences in the faecal microbiome of obese and non-obese pregnant women: a matched cohort study in Sweden
Background: Differences in the gut microbiome between lean and obese individuals, even twins, have been recognized for over a decade. The causative role of the microbiome in obesity is known from both mouse and human studies. In parallel, the gut microbiome has been implicated in the most common complications of pregnancy, including preterm birth, gestational diabetes mellitus, and gestational hypertension. Despite obesity being a well-established risk factor for these complications, the composition of the gut microbiome of obese pregnant individuals has not yet been studied. Here, we have examined the differences in the faecal microbiota between lean ( n = 746) and obese ( n = 254) pregnant women in Sweden, at two timepoints in pregnancy. Results: The differences in the faecal microbiome of one thousand lean and obese persons persist during gestation. Obese individuals have a less diverse and less rich microbiome throughout all trimesters of pregnancy. In the first trimester, 9 species differ significantly between lean and obese individuals, and 35 in the early third trimester, after adjusting for confounders. However, only one species remained significant after further adjusting for bowel transit time, which differed significantly between lean and obese participants. Additionally, obese individuals harbored a consistently lower potential to produce propionate in their gut microbiomes, even after adjustments. Conclusions: The faecal microbiome adapts to pregnancy with some key differences between lean and obese mothers, even in late pregnancy. Crucially, there is an over-abundance of opportunistic pathogens in the microbiome of obese pregnant women in the third trimester. This may be a potential underexplored mechanism explaining the increased rates of pregnancy complications among obese patients. Diet, probiotics, or medication interventions to correct the gut microbiome of pregnant obese individuals could potentially improve their pregnancy outcomes.
- 15 November 2025
- Published by Springer Nature in BMC Microbiology
- Vol. 25 (1) , 750
Open AccessDifferences in the faecal microbiome of obese and non-obese pregnant women: a matched cohort study in Sweden
Background: Differences in the gut microbiome between lean and obese individuals, even twins, have been recognized for over a decade. The causative role of the microbiome in obesity is known from both mouse and human studies. In parallel, the gut microbiome has been implicated in the most common complications of pregnancy, including preterm birth, gestational diabetes mellitus, and gestational hypertension. Despite obesity being a well-established risk factor for these complications, the composition of the gut microbiome of obese pregnant individuals has not yet been studied. Here, we have examined the differences in the faecal microbiota between lean ( n = 746) and obese ( n = 254) pregnant women in Sweden, at two timepoints in pregnancy. Results: The differences in the faecal microbiome of one thousand lean and obese persons persist during gestation. Obese individuals have a less diverse and less rich microbiome throughout all trimesters of pregnancy. In the first trimester, 9 species differ significantly between lean and obese individuals, and 35 in the early third trimester, after adjusting for confounders. However, only one species remained significant after further adjusting for bowel transit time, which differed significantly between lean and obese participants. Additionally, obese individuals harbored a consistently lower potential to produce propionate in their gut microbiomes, even after adjustments. Conclusions: The faecal microbiome adapts to pregnancy with some key differences between lean and obese mothers, even in late pregnancy. Crucially, there is an over-abundance of opportunistic pathogens in the microbiome of obese pregnant women in the third trimester. This may be a potential underexplored mechanism explaining the increased rates of pregnancy complications among obese patients. Diet, probiotics, or medication interventions to correct the gut microbiome of pregnant obese individuals could potentially improve their pregnancy outcomes.
- Open Access
Metabolic differences in the maternal gut microbiome precede the birth of large-for-gestational-age infants: A nested case-control study
Background: Neonatal size influences newborn health and is affected by prenatal factors, such as the maternal gut microbiome, which impacts maternal metabolism and fetal growth. Methods: A nested case-control study (1:2 matched) was conducted within the Swedish Maternal Microbiome (SweMaMi, 2017–2021) cohort to investigate the associations between maternal gut microbiome profiles during pregnancy and the risk of delivering large-for-gestational-age (LGA; birth weight >90th percentile) infants compared to appropriate-for-gestational-age (AGA; birth weight 10-90th percentile) infants, with a focus on dietary influence. Shotgun metagenomics enabled taxonomic and functional profiling of fecal samples collected during early (TP1: 10–20 weeks; n = 245:490) and late pregnancy (TP2: 28–32 weeks; n = 157:314). Additionally, we analyzed within-group changes in microbiome diversity from TP1 to TP2 to compare longitudinal patterns between the groups. Results: At TP1, microbial species richness was higher in mothers of LGA infants (p = 0.01, 95% CI: 3.26 to 24.9), but this difference was not observed at TP2 (p = 0.30, 95% CI: –7.04 to 22.7). Beta diversity (overall microbial structure) did not differ significantly between groups at either time point. Within-sample diversity, as measured by the Shannon index, showed a significantly greater decline in the LGA group compared to the AGA group (p = 0.03, 95% CI: –0.13 to –0.007), suggesting a loss of microbial diversity specific to the LGA group over time. Evenness also declined in both groups, but the change was significantly more pronounced in the LGA group (p = 0.047, 95% CI: –0.02 to –0.0001. At TP1, the LGA group was functionally enriched in proteolytic pathways, while the AGA, group was associated with short-chain fatty acid (SCFA) production, a connection that remained at TP2. In contrast, the LGA group displayed a shift toward a pathway involved in glucose production. Limitations: Reliance on self-reported dietary data, lack of physical activity and pre-pregnancy diet information, and a highly educated study population may limit generalizability. Conclusion: Early pregnancy gut microbiome diversity and function, along with maternal factors, may contribute to the risk of fetal overgrowth. While microbiome diversity converges between cases and controls at a later time-point, this is not enough to mitigate risk.
Open AccessMetabolic differences in the maternal gut microbiome precede the birth of large-for-gestational-age infants: A nested case-control study
Background: Neonatal size influences newborn health and is affected by prenatal factors, such as the maternal gut microbiome, which impacts maternal metabolism and fetal growth. Methods: A nested case-control study (1:2 matched) was conducted within the Swedish Maternal Microbiome (SweMaMi, 2017–2021) cohort to investigate the associations between maternal gut microbiome profiles during pregnancy and the risk of delivering large-for-gestational-age (LGA; birth weight >90th percentile) infants compared to appropriate-for-gestational-age (AGA; birth weight 10-90th percentile) infants, with a focus on dietary influence. Shotgun metagenomics enabled taxonomic and functional profiling of fecal samples collected during early (TP1: 10–20 weeks; n = 245:490) and late pregnancy (TP2: 28–32 weeks; n = 157:314). Additionally, we analyzed within-group changes in microbiome diversity from TP1 to TP2 to compare longitudinal patterns between the groups. Results: At TP1, microbial species richness was higher in mothers of LGA infants (p = 0.01, 95% CI: 3.26 to 24.9), but this difference was not observed at TP2 (p = 0.30, 95% CI: –7.04 to 22.7). Beta diversity (overall microbial structure) did not differ significantly between groups at either time point. Within-sample diversity, as measured by the Shannon index, showed a significantly greater decline in the LGA group compared to the AGA group (p = 0.03, 95% CI: –0.13 to –0.007), suggesting a loss of microbial diversity specific to the LGA group over time. Evenness also declined in both groups, but the change was significantly more pronounced in the LGA group (p = 0.047, 95% CI: –0.02 to –0.0001. At TP1, the LGA group was functionally enriched in proteolytic pathways, while the AGA, group was associated with short-chain fatty acid (SCFA) production, a connection that remained at TP2. In contrast, the LGA group displayed a shift toward a pathway involved in glucose production. Limitations: Reliance on self-reported dietary data, lack of physical activity and pre-pregnancy diet information, and a highly educated study population may limit generalizability. Conclusion: Early pregnancy gut microbiome diversity and function, along with maternal factors, may contribute to the risk of fetal overgrowth. While microbiome diversity converges between cases and controls at a later time-point, this is not enough to mitigate risk.
- Open Access
- 2 June 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-9
Wastewater surveillance of SARS-CoV-2 from aircraft to citywide monitoring
Wastewater monitoring is highly efficient in SARS-CoV-2 surveillance for tracking virus spread through travel, surpassing traditional airport passenger testing. This study explored the links between SARS-CoV-2 contents and variants from aircraft to city, assessing the impact of detected variants from international travellers versus the local population. A total of 969 variants using next-generation sequencing (NGS) were examined to understand the links between—aircraft, Arlanda airport, wastewater treatment plants (WWTPs), and Stockholm city—and compared these to variants detected in Stockholm hospitals from January to May 2023. SARS-CoV-2 contents in WWTPs reflected local infection rates, requiring analysis from multiple plants for an accurate city-wide infection assessment. Variants initially detected in aircraft arriving from China did not spread widely during the study period. RT-qPCR is adequate for the detection of specific variants in wastewater, including Variants Under Monitoring. However, NGS remains a powerful method for identifying novel variants. Wastewater monitoring was more effective than clinical testing in the early detection of specific variants, with notable delays observed in clinical surveillance. Furthermore, a broad range of variants are detected in wastewater that surpasses clinical tests. This underscores the vital role of wastewater-based epidemiology in managing future outbreaks and enhancing global health security.
- 2 June 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-9
Open AccessWastewater surveillance of SARS-CoV-2 from aircraft to citywide monitoring
Wastewater monitoring is highly efficient in SARS-CoV-2 surveillance for tracking virus spread through travel, surpassing traditional airport passenger testing. This study explored the links between SARS-CoV-2 contents and variants from aircraft to city, assessing the impact of detected variants from international travellers versus the local population. A total of 969 variants using next-generation sequencing (NGS) were examined to understand the links between—aircraft, Arlanda airport, wastewater treatment plants (WWTPs), and Stockholm city—and compared these to variants detected in Stockholm hospitals from January to May 2023. SARS-CoV-2 contents in WWTPs reflected local infection rates, requiring analysis from multiple plants for an accurate city-wide infection assessment. Variants initially detected in aircraft arriving from China did not spread widely during the study period. RT-qPCR is adequate for the detection of specific variants in wastewater, including Variants Under Monitoring. However, NGS remains a powerful method for identifying novel variants. Wastewater monitoring was more effective than clinical testing in the early detection of specific variants, with notable delays observed in clinical surveillance. Furthermore, a broad range of variants are detected in wastewater that surpasses clinical tests. This underscores the vital role of wastewater-based epidemiology in managing future outbreaks and enhancing global health security.